Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Autism Spectrum Disorder
In brief
This is a randomized interventional study designed to evaluate the effects of repetitive Transcranial Magnetic Stimulation (rTMS) on neural and behavioral facets of social cognition in adults with autism spectrum disorder (ASD).
Key facts
- Study ID
- NCT04936009
- Run by
- Yale University
- People needed
- 60
- Starts
- 2022-03-17
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-02-09
Who can join
Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Individuals between the ages of 18 and 40 years old with typical development or with a diagnosis of autism spectrum disorder.
- Individuals able to participate in an EEG and eye-tracking experiment.
You may not qualify if…
- Participants reporting significant head trauma or serious brain illness.
- Participants with major psychiatric illness that would preclude completion of study measures.
- Participants with a history of serious medical illness, stroke, seizures, epileptiform EEG abnormalities, or family history of seizures.
- Participants taking prescription medications that may affect cognitive processes under study.
- Participants who have taken alcohol or recreational drugs within the preceding 24 hours.
- Females of known/suspected pregnancy or who test positive on a pregnancy test.
- Participants with a history of metalworking or injury by shrapnel or metallic objects are also excluded.
- Participants with a history of prior TMS therapy or use of an investigational drug within 12 weeks of visit.
- Participants with an IQ (intelligence quotient) below 80.
Where it is running
- Yale University Child Study Center — New Haven, Connecticut, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.